Workers’ compensation cases resulting in the need for home health care require specialized expertise to provide a seamless and customized transition of care. Whether an individual requires simple or complex home health, Apricus leverages a strong national network of credentialed home health care providers to coordinate the appropriate level of care for each injured employee, in a timely and compassionate manner.
Safe2Work can help “overworked HR departments” wade through the COVID-19 crisis, the app’s creators say.
In workers’ compensation, catastrophic injuries transpire with relatively low frequency. When they do occur, however, payers demand an all-hands-on-deck approach that calls upon specialized experts to manage specific aspects of these complicated claims.
Latest milestone achieved in less than a year due to rapid adoption and utilization of the patented collision repair diagnostic system
Designation makes Mitchell the exclusive supplier of diagnostic and calibration tools for certified PDR technicians.
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA). Seglentis contains tramadol, a short-acting opioid, and celecoxib, a non-steroidal anti-inflammatory drug (NSAID), and is indicated for adults in the management of acute pain that is severe enough to require an opioid analgesic and for which alternative treatments are inadequate.